Skip to main content

Market Overview

25 Healthcare Stocks Moving In Wednesday's Pre-Market Session

Share:

Gainers

  • Immuron, Inc. (NASDAQ: IMRN) shares surged 34.3% to $3.60 during Wednesday's pre-market session. The market cap stands at $12.5 million.
  • Organovo Holdings, Inc. (NASDAQ: ONVO) shares surged 12.4% to $0.30. The market value of their outstanding shares is at $34.3 million. According to the most recent rating by H.C. Wainwright, on August 08, the current rating is at Neutral.
  • Axsome Therapeutics, Inc. (NASDAQ: AXSM) stock moved upwards by 9.6% to $18.31. The market value of their outstanding shares is at $888.3 million. According to the most recent rating by William Blair, on September 18, the current rating is at Outperform.
  • Aimmune Therapeutics, Inc. (NASDAQ: AIMT) shares surged 9.4% to $22.40. The market cap seems to be at $1.3 billion. The most recent rating by Stifel, on September 16, is at Hold, with a price target of $30.00.
  • Ocugen, Inc. (NASDAQ: OCGN) stock surged 8.2% to $2.37. The market cap seems to be at $20.8 million.
  • TrovaGene, Inc. (NASDAQ: TROV) shares increased by 6.7% to $1.43. The market value of their outstanding shares is at $9.2 million.
  • Jaguar Health, Inc. (NASDAQ: JAGX) shares rose 4.9% to $1.28. The market value of their outstanding shares is at $9.0 million. The most recent rating by Ladenburg Thalmann, on September 12, is at Buy, with a price target of $5.00.
  • Tetraphase Pharmaceutical, Inc. (NASDAQ: TTPH) stock moved upwards by 4.1% to $5.60. The market value of their outstanding shares is at $14.8 million. According to the most recent rating by H.C. Wainwright, on September 03, the current rating is at Neutral.
  • Calithera Biosciences, Inc. (NASDAQ: CALA) stock moved upwards by 3.4% to $2.73. The market cap seems to be at $191.4 million.
  • Intec Pharma, Inc. (NASDAQ: NTEC) shares moved upwards by 2.9% to $0.75. The market cap stands at $28.4 million. According to the most recent rating by H.C. Wainwright, on August 07, the current rating is at Neutral.
  • Amicus Therapeutics, Inc. (NASDAQ: FOLD) stock surged 2.7% to $8.25. The market cap seems to be at $2.0 billion.
  • Valeritas Holdings, Inc. (NASDAQ: VLRX) stock surged 2.3% to $1.32. The market cap stands at $11.5 million.

 

Losers

  • Savara, Inc. (NASDAQ: SVRA) stock plummeted 59.7% to $1.00 during Wednesday's pre-market session. The market cap seems to be at $131.8 million.
  • Lantheus Holdings, Inc. (NASDAQ: LNTH) stock plummeted 19.0% to $19.46. The market cap seems to be at $1.0 billion.
  • Guardion Health Sciences, Inc. (NASDAQ: GHSI) shares fell 14.1% to $0.55. The market value of their outstanding shares is at $28.3 million.
  • Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) shares declined 7.1% to $4.60. The market value of their outstanding shares is at $447.6 million. The most recent rating by Brookline Capital, on July 30, is at Buy, with a price target of $10.00.
  • Sienna Biopharmaceuticals, Inc. (NASDAQ: SNNA) stock fell 5.2% to $0.28. The market cap stands at $3.4 million. The most recent rating by BMO Capital, on September 05, is at Outperform, with a price target of $3.00.
  • Cellectis, Inc. (NASDAQ: CLLS) stock decreased by 4.8% to $10.59. The market cap stands at $461.2 million. According to the most recent rating by BTIG, on August 09, the current rating is at Buy.
  • Viveve Medical, Inc. (NASDAQ: VIVE) stock decreased by 3.3% to $4.65. The market cap seems to be at $3.3 million. According to the most recent rating by Ladenburg Thalmann, on July 24, the current rating is at Neutral.
  • HEXO, Inc. (NYSE: HEXO) stock decreased by 2.9% to $3.72. The market value of their outstanding shares is at $1.0 billion.
  • Cancer Genetics, Inc. (NASDAQ: CGIX) stock decreased by 2.5% to $0.15. The market cap stands at $6.1 million.
  • Applied Genetic Tech, Inc. (NASDAQ: AGTC) shares declined 2.4% to $4.04. The market cap seems to be at $68.1 million. The most recent rating by BMO Capital, on September 27, is at Outperform, with a price target of $9.00.
  • Acasti Pharma, Inc. (NASDAQ: ACST) shares declined 2.1% to $1.82. The market value of their outstanding shares is at $173.3 million. The most recent rating by B. Riley FBR, on August 29, is at Buy, with a price target of $7.75.
  • Genfit, Inc. (NASDAQ: GNFT) shares plummeted 2.1% to $14.93. The market cap stands at $661.5 million.
  • GlaxoSmithKline, Inc. (NYSE: GSK) shares plummeted 2.0% to $41.47. The market value of their outstanding shares is at $106.9 billion. According to the most recent rating by Societe Generale, on September 03, the current rating is at Buy.
 

Related Articles (ACST + AGTC)

View Comments and Join the Discussion!

Posted-In: Healthcare Stocks Pre-Market MoversNews Movers & Shakers Pre-Market Outlook Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com